This invention relates to novel tris(hydroxymethyl)aminomethane choline and N methyl D glucamine salt forms of the following Compound (1) and methods for the preparation thereof pharmaceutical compositions thereof and their use in the treatment of Hepatitis C Viral (HCV) infection: